Dermatol. praxi. 2009;3(2):89-91

Cases of interest from clinical-pathological practice

MUDr. Zoltán Szép, PhD1,3,2
1 CYTOPATHOS spol. s. r. o., bioptické, cytologické a skríningové laboratórium, Bratislava
2 Katedra dermatovenerológie FZ©© SZU, Bratislava
3 Koľné oddelenie Ministerstva obrany SR, Bratislava

The author describes three rare dermatological nosological entities from his clinical-pathological practice. He highlights the diagnostic

significance and contribution of biopsy examination in clinical dermatology and the need for close clinical-pathological correlation and

cooperation.

Keywords: clinical dermatology, dermatohistopathology, clinical-pathological correlation.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Szép Z. Cases of interest from clinical-pathological practice. Dermatol. praxi. 2009;3(2):89-91.
Download citation

References

  1. Lee BJ, Mancini AJ, Renucci J, et al. Full-thickness surgical excision for the treatment of inflammatory linear verrucous epidermal nevus. Ann Plast Surg, 2001; 47(3): 285-292. Go to original source... Go to PubMed...
  2. Dereure O, Paillet C, Bonnel F, et al. Inflammatory linear verrucous epidermal naevus with auto-immune thyroiditis: coexistence of two auto-immune epithelial inflammations? Acta Derm Venereol, 1994; 74(3): 208-209. Go to PubMed...
  3. Welch ML, Smith KJ, Skelton HG, et al. Immunohistochemical features in inflammatory linear verrucous epidermal nevi suggest a distinctive pattern of clonal dysregulation of growth. J Am Acad Dermatol, 1993; 29(2Pt1): 242-248. Go to original source... Go to PubMed...
  4. Happle R. Transposable elements and the lines of Blaschko: a new perspective. Dermatology, 2002; 204(1): 4-7. Go to original source... Go to PubMed...
  5. Bohm I, Bieber T, Bauer R. Succesful therapy of an ILVEN in a 7-year-old girl with calcipotriol. Hautarzt, 1999; 50(11): 812-814. Go to original source... Go to PubMed...
  6. Kim JJ, Chang MW, Shwayder T. Topical tretinoin and 5-fluorouracil in the treatment of linear verrucous epidermal nevus. J Am Acad Dermatol, 2000; 43(1Pt1): 129-132. Go to original source... Go to PubMed...
  7. Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli: overview and review of the literature. Acta Derm. Venereol, 1997; 77(3): 207-213. Go to PubMed...
  8. Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor supressor protein in porokeratosis. Arch Dermatol, 1994; 130(2): 187-190. Go to original source... Go to PubMed...
  9. Harrison S, Sinclair R. Porokeratosis of Mibelli: succesful treatment with topical 5% imiquimod cream. Australas J Dermatol, 2003; 44(4): 281-283. Go to original source... Go to PubMed...
  10. Alster TS, Nanni CA. Succesful treatment of porokeratosis with 585 nm pulsed dye laser irradiation. Cutis, 1999; 63(5): 265-266. Go to PubMed...
  11. Cavicchini S, Tourlaki A. Succesful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate - photodynamic therapy. J Dermatolog Treat, 2006; 17(3): 190-191. Go to original source... Go to PubMed...
  12. Rabbin PE, Baldwin HE. Treatment of porokeratosis of Mibelli with CO2 laser vaporization versus surgical excision with split-thickness skin graft. A comparison. J Dermatol Surg Oncol, 1993; 19(3): 199-202. Go to original source... Go to PubMed...
  13. Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dermatol, 1995; 131(4): 496-497. Go to original source... Go to PubMed...
  14. Dolken R, Weigel S, Schroder H, et al. Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous systém. J Pediatr Hematol Oncol, 2006; 28(2): 95-97. Go to original source... Go to PubMed...
  15. Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol, 2005; 29(1): 21-28. Go to original source... Go to PubMed...
  16. Weston LW, Lane TA, Morelli GJ. Color textbook of pediatric dermatology. 3rd ed. St. Louis: Mosby, 2002: 177-178 s.
  17. Zvulunov A, Barak Y, Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: world statistical analysis. Arch Dermatol, 1995; 131(8): 904-908. Go to original source... Go to PubMed...
  18. Chang MW, Frieden IJ, Good W. The risk of intraocular juvenile xanthogranuloma: survey of current practices and assesment of risk. J Am Acad Dermatol, 1996; 34(3): 445-449. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.